Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Wyeth Rapamune Off-Label Marketing Settlement Will Not Alter Pfizer’s CIA

31 Jul 2013

• By Brenda Sandburg

Related Content

Pfizer's Record-Breaking $2.3 Bil. Settlement With U.S. Attorney Imposes New Restrictions on Corporate Behavior

07 Sep 2009

Pfizer On Track To Settle Rapamune Investigation; Protonix Probe Still Unresolved

02 Nov 2012

Related Companies

Pfizer Inc.

Additional Topics

United States Legal Issues Advertising, Marketing & Sales BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.